Literature DB >> 8660965

Structure and organization of the human metaxin gene (MTX) and pseudogene.

G L Long1, S Winfield, K W Adolph, E I Ginns, P Bornstein.   

Abstract

Metaxin encodes a mitochondrial protein and is an essential nuclear gene in mice. The cDNA sequence and genomic organization of the human metaxin gene (MTX) have now been determined. MTX is 6 kb and consists of eight protein-encoding exons. The gene is contiguous to thrombospondin 3 (THBS3) and to the pseudogene for glucocerebrosidase (psGBA), but it transcribed in a direction opposite to the latter two genes. Thus, MTX and THBS3 share a common promoter region and are transcribed convergently, whereas MTX and psGBA are transcribed convergently and have closed apposed polyadenylation sites. Human metaxin contains 317 amino acids and is 91.5% identical to mouse metaxin. Metaxin is rich in leucine (14.2%) and in basic (12.9%) and acidic (12.0%) amino acids. The predicted protein lacks an amino-terminal signal sequence and N-glycosylation sites, but contains a putative transmembrane domain near its carboxy terminus. A DNA duplication has led to a direct repeat and the evolution of a pseudogene for GBA. A pseudogene for metaxin (psMTX) is also located within the 16 kb of DNA separating GBA from psGBA. The psMTX sequence is nearly identical to the 3' part of exon 2 through exon 8 of MTX, and both the intronic and the 3'-flanking sequences are highly conserved. Thus, there is a 278 amino acid open reading frame that is 97.8% identical to metaxin. However, psMTX lacks the first intron and promoter present in MTX, and at least in liver, the pseudogene is not expressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660965     DOI: 10.1006/geno.1996.0181

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2011-08-12       Impact factor: 2.660

2.  Identification of recombinant alleles using quantitative real-time PCR implications for Gaucher disease.

Authors:  Arash Velayati; Melanie A Knight; Barbara K Stubblefield; Ellen Sidransky; Nahid Tayebi
Journal:  J Mol Diagn       Date:  2011-07       Impact factor: 5.568

3.  Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease.

Authors:  N Tayebi; S Cushner; E Sidransky
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  Gaucher disease plus.

Authors:  E Sidransky; E I Ginns
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

5.  D409H/D409H genotype in Gaucher-like disease.

Authors:  E Uyama; M Uchino; H Ida; Y Eto; M Owada
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 6.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

7.  SP1-binding elements, within the common metaxin-thrombospondin 3 intergenic region, participate in the regulation of the metaxin gene.

Authors:  M Collins; P Bornstein
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

8.  Type 2 Gaucher disease in an infant despite a normal maternal glucocerebrosidase gene.

Authors:  Ermias Hagege; Richard J Grey; Grisel Lopez; Tamanna Roshan Lal; Ellen Sidransky; Nahid Tayebi
Journal:  Am J Med Genet A       Date:  2017-11-01       Impact factor: 2.802

Review 9.  Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.

Authors:  N Gupta; I M Oppenheim; E F Kauvar; N Tayebi; E Sidransky
Journal:  Blood Cells Mol Dis       Date:  2010-09-28       Impact factor: 3.039

10.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.

Authors:  Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.